This case series examines the use of thrombolysis with Alteplase in the management of acute ischemic stroke at a tertiary care center in Bangladesh. The study aims to evaluate the effectiveness and safety of Alteplase thrombolysis in a resource-limited setting and provide valuable insights into its outcomes. Retrospective analysis of patient records was conducted, including demographic data, clinical characteristics, stroke severity scores, treatment initiation time, radiological findings, complications, and functional outcomes. The results contribute to the understanding of Alteplase thrombolysis in the context of acute ischemic stroke in Bangladesh.

Thrombolysis, Alteplase, acute ischemic stroke

GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol2019; 18: 439–58

Islam MN, Moniruzzaman M, Khalil MI, Basri R, Alam MK, Loo KW. Burden of stroke in Bangladesh. Int J Stroke 2013; 8:211-3

Katan M, Luft A. Global burden of stroke. SeminNeurol2018; 38:208-11

Mamin FA, Islam MS, Rumana FS, Faruqui F. Profle of stroke patients treated at a rehabilitation centre in Bangladesh. BMC Res Notes 2017; 10:520

Giang KW, Mandalenakis Z, Nielsen S, Bjorck L, Lappas G, Adiels M, et al. Long-term trends in the prevalence of patients hospitalized with ischemic stroke from 1995 to 2010 in Sweden. PLoS ONE 2017;12: e0179658

Feigin VL, Florouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014; 383: 245–254

Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 2007; 38:967-73

Kassem-Moussa H, Graffagnino C. Nonocclusion and spontaneous recanalization rates in acute ischemic stroke: a review of cerebral angiography studies. Arch Neurol2002; 59:1870-3

Fugate JE, Rabinstein AA. Absolute and relative contraindications to IV rt-PA for acute ischemic stroke. The Neurohospitalist2015; 5:110-21

Dhillon S. Alteplase: a review of its use in the management of acute ischaemic stroke. CNS Drugs 2012; 26:899-926

Syalaja PN, Dong W, Grotta JC, Miller MK, Tomita K, Hamilton S, et al. Safety outcomes of alteplase among acute ischemic stroke patients with special characteristics. Neurocrit Care 2007; 6:181-5

Anderson CS, Robinson T, Lindley RI, Arima H, Lavados PM, Lee TH, et al. Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. N Engl J Med 2016; 374:2313-23